Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phil Greenfield

Set Alert for Articles By Phil Greenfield

Latest From Phil Greenfield

RSNA 2019: AI, Machine Learning Continue To Dominate Developments In Radiology

Artificial intelligence (AI) and machine learning took center stage at this year’s Radiological Society of North America meeting in Chicago, and the pervasiveness of AI tech in new product launches was further emphasized at the RSNA’s expanded AI Showcase exhibit.

Artificial Intelligence Diagnostic Imaging

AHA 2019: Cardiawave Sees Positive Early Results For Non-Invasive Valve Disease Treatment

The French start-up claims first-in-man success for heart valve “softening” treatment and plans further trials for an EU launch.

Clinical Trials Innovation

Market Intel: Precision Diagnostics And Focal Treatments Offer Personalized Approach To Prostate Cancer

The combined market for prostate cancer diagnostics and minimally invasive treatments is set to increase from $900m to $1.46bn in the next five years. But conservative treatment, or watchful waiting, is popular, limiting growth of newer, focal treatments.

Market Intelligence Cancer

TCT 2019: IDEAL LM Inconclusive, While Onyx ONE Boosts Polymer-Based DES

Data from two late-breaking drug-eluting stent trials, presented on 26 September at Transcatheter Cardiovascular Therapeutics meeting in San Francisco, prompted mixed reactions from interventional cardiologists.

Clinical Trials Research & Development

In search of the next MedTech Idol

You’re an inventor with a great medtech idea that has yet to receive funding and want feedback from unbiased peers and potential investors. Or perhaps you’ve got your first product to a clinical prototype and you can’t seem to raise that essential funding to push into product development. What do you do now?

Medical Device

ANALYSIS: Australian device approvals could slide further with scrutiny hurdles

The number of new medtech products on the Australian market has slowly declined over the six months to March 2013 and looks set to fall further if, as expected, tougher approval requirements are introduced for higher risk products.

See All
UsernamePublicRestriction

Register